Lannett Co Inc Net Income 2006-2019 | LCI

Lannett Co Inc net income from 2006 to 2019. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
Lannett Co Inc Annual Net Income
(Millions of US $)
2019 $-272
2018 $29
2017 $-1
2016 $45
2015 $150
2014 $57
2013 $13
2012 $4
2011 $-0
2010 $8
2009 $7
2008 $-2
2007 $-7
2006 $5
2005 $-33
Lannett Co Inc Quarterly Net Income
(Millions of US $)
Q1 2019 $-12
Q4 2019 $-8
Q3 2019 $11
Q2 2018 $12
Q1 2018 $-288
Q4 2018 $-11
Q3 2018 $13
Q2 2017 $14
Q1 2017 $13
Q4 2017 $6
Q3 2017 $15
Q2 2016 $8
Q1 2016 $-29
Q4 2016 $4
Q3 2016 $-5
Q2 2015 $14
Q1 2015 $33
Q4 2015 $34
Q3 2015 $36
Q2 2014 $45
Q1 2014 $35
Q4 2014 $24
Q3 2014 $23
Q2 2013 $17
Q1 2013 $-6
Q4 2013 $4
Q3 2013 $4
Q2 2012 $3
Q1 2012 $3
Q4 2012 $1
Q3 2012 $2
Q2 2011 $1
Q1 2011 $0
Q4 2011 $-2
Q3 2011 $-0
Q2 2010 $2
Q1 2010 $-0
Q4 2010 $3
Q3 2010 $2
Q2 2009 $0
Q1 2009 $3
Q4 2009 $2
Q3 2009 $1
Q2 2008 $2
Q1 2008 $1
Q4 2008 $-0
Q3 2008 $-1
Q2 2007 $-1
Q1 2007 $-0
Q4 2007 $-3
Q3 2007 $-7
Q2 2006 $1
Q1 2006 $1
Q4 2006 $1
Q3 2006 $1
Q2 2005 $1
Q1 2005 $2
Q4 2005 $-6
Q3 2005 $-29
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.354B $0.655B
Lannett Company manufactures and distributes high quality affordable generic medications that are the therapeutic equivalent of the brand-name pharmaceuticals. Their portfolio consists of numerous products across a wide range of therapeutic areas. Lannett believes that their ability to select viable products for development, efficiently develop such products, including obtaining any applicable regulatory approvals, vertically integrate themselves into certain specialty markets and achieve economies in production are all critical for their success in the generic pharmaceutical industry in which they operate. Lannett Company, Inc., continues to dedicate significant capital toward developing new products as they believe their success is linked to their ability to continually introduce new generic products into the marketplace.
Stock Name Country Market Cap PE Ratio
Takeda Pharmaceutical (TAK) Japan $62.561B 9.89
Zoetis (ZTS) United States $58.852B 35.20
Astellas Pharma (ALPMY) Japan $32.261B 16.11
Eisai (ESALY) Japan $20.942B 40.38
Grifols, S.A (GRFS) Spain $15.594B 20.43
UCB SA (UCBJF) Belgium $15.483B 0.00
Merck (MKGAF) Germany $14.630B 19.97
Neurocrine Biosciences (NBIX) United States $10.430B 492.39
Ono Pharmaceutical (OPHLF) Japan $9.450B 20.20
Ionis Pharmaceuticals (IONS) United States $8.678B 17.58
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $8.638B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $8.380B 10.70
Catalent (CTLT) United States $7.634B 31.06
IPSEN SA ADR (IPSEY) France $7.374B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $6.529B 98.87
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.226B 0.00
Orion OYJ (ORINY) Finland $5.849B 30.12
STADA ARZNEIMI (STDAF) Germany $5.375B 0.00
Hypermarcas (HYPMY) Brazil $4.932B 17.73
FibroGen (FGEN) United States $4.127B 121.28
United Therapeutics (UTHR) United States $4.059B 0.00
Nektar Therapeutics (NKTR) United States $3.800B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.641B 13.31
Sage Therapeutics (SAGE) United States $3.558B 0.00
Evotec AG (EVTCY) Germany $3.498B 57.24
PTC Therapeutics (PTCT) United States $2.966B 0.00
ArQule (ARQL) United States $2.439B 0.00
Heron Therapeutics (HRTX) United States $2.304B 0.00
Xencor (XNCR) United States $2.160B 65.65
Portola Pharmaceuticals (PTLA) United States $2.113B 0.00
Zogenix (ZGNX) United States $2.093B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.943B 61.95
Pacira Pharmaceuticals (PCRX) United States $1.900B 56.22
Tilray (TLRY) Canada $1.829B 0.00
ChemoCentryx (CCXI) United States $1.812B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.741B 0.00
USANA Health Sciences (USNA) United States $1.621B 17.30
Corcept Therapeutics (CORT) United States $1.551B 18.85
Enanta Pharmaceuticals (ENTA) United States $1.268B 28.95
CLINIGEN GP (CLIGF) United Kingdom $1.245B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.176B 0.00
Spectrum Pharmaceuticals (SPPI) United States $1.130B 0.00
Karyopharm Therapeutics (KPTI) United States $1.049B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.041B 7.10
Radius Health (RDUS) United States $1.019B 0.00
Endo (ENDP) Ireland $0.996B 1.83
Aerie Pharmaceuticals (AERI) United States $0.993B 0.00
Flexion Therapeutics (FLXN) United States $0.794B 0.00
Akebia Therapeutics (AKBA) United States $0.747B 0.00
Collegium Pharmaceutical (COLL) United States $0.684B 0.00
TherapeuticsMD (TXMD) United States $0.643B 0.00
Dermira (DERM) United States $0.636B 0.00
ImmunoGen (IMGN) United States $0.545B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.530B 0.00
Translate Bio (TBIO) United States $0.508B 0.00
Ardelyx (ARDX) United States $0.472B 0.00
Organogenesis Holdings (ORGO) United States $0.461B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.443B 53.75
Aptorum Group (APM) Hong Kong, SAR China $0.442B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.435B 18.74
Harpoon Therapeutics (HARP) United States $0.431B 0.00
Molecular Templates (MTEM) United States $0.412B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.410B 0.00
OptiNose (OPTN) United States $0.394B 0.00
Indivior (INVVY) United States $0.389B 1.41
Rigel Pharmaceuticals (RIGL) United States $0.382B 0.00
Siga Technologies (SIGA) United States $0.379B 8.65
Recro Pharma (REPH) United States $0.378B 0.00
DURECT (DRRX) United States $0.367B 0.00
Innate Pharma SA (IPHYF) France $0.358B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.318B 0.00
Jounce Therapeutics (JNCE) United States $0.304B 4.06
Rafael Holdings (RFL) United States $0.303B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.285B 0.00
KalVista Pharmaceuticals (KALV) United States $0.276B 0.00
Concordia (CXRXF) Canada $0.269B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.267B 0.00
Calithera Biosciences (CALA) United States $0.243B 0.00
GlycoMimetics (GLYC) United States $0.242B 0.00
Xeris Pharmaceuticals (XERS) United States $0.241B 0.00
Aquestive Therapeutics (AQST) United States $0.193B 0.00
Ocular Therapeutix (OCUL) United States $0.192B 0.00
Nature's Sunshine Products (NATR) United States $0.191B 32.93
AcelRx Pharmaceuticals (ACRX) United States $0.190B 0.00
Concert Pharmaceuticals (CNCE) United States $0.188B 0.00
Taiwan Liposome (TLC) Taiwan $0.178B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.170B 0.00
IMV INC (IMV) Canada $0.157B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.146B 0.00
MEI Pharma (MEIP) United States $0.144B 0.00
Redhill Biopharma (RDHL) Israel $0.136B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.130B 0.00
CannTrust Holdings (CTST) Canada $0.116B 0.00
CV Sciences (CVSI) United States $0.111B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.094B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.088B 0.00
Capnia (SLNO) United States $0.084B 0.00
MediWound (MDWD) Israel $0.082B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.079B 23.64
Otonomy (OTIC) United States $0.077B 0.00
Champions Oncology (CSBR) United States $0.077B 0.00
Aclaris Therapeutics (ACRS) United States $0.075B 0.00
Neos Therapeutics (NEOS) United States $0.074B 0.00
PolarityTE (PTE) United States $0.073B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.071B 0.00
CTI BioPharma (CTIC) United States $0.070B 0.00
Infinity Pharmaceuticals (INFI) United States $0.067B 0.00
Nivalis Therapeutics (ALPN) United States $0.067B 0.00
Pharmaxis (PXSLY) Australia $0.065B 0.00
Forward Pharma (FWP) Denmark $0.065B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.063B 0.00
RENEURON GP (RNUGF) United Kingdom $0.062B 0.00
Genocea Biosciences (GNCA) United States $0.059B 0.00
Novan (NOVN) United States $0.059B 0.00
Natural Alternatives (NAII) United States $0.057B 14.29
Opiant Pharmaceuticals (OPNT) United States $0.057B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.056B 0.00
Medicure (MCUJF) Canada $0.055B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.053B 0.00
Mast Therapeutics (SVRA) United States $0.050B 0.00
AgeX Therapeutics (AGE) United States $0.049B 0.00
SCYNEXIS (SCYX) United States $0.046B 0.00
ElectroCore (ECOR) United States $0.046B 0.00
Iterum Therapeutics (ITRM) Ireland $0.044B 0.00
IsoRay (ISR) United States $0.042B 0.00
Opexa Therapeutics (ACER) United States $0.040B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.038B 0.00
Mannatechorporated (MTEX) United States $0.038B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.032B 0.00
Jaguar Animal Health (JAGX) United States $0.030B 0.00
PharmAthene (ALT) United States $0.028B 0.00
Shineco (TYHT) China $0.028B 0.00
India Globalization Capital (IGC) United States $0.027B 0.00
Biomerica (BMRA) United States $0.026B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.026B 0.00
ProPhase Labs (PRPH) United States $0.023B 0.00
Cardiome Pharma (CORV) Canada $0.023B 0.00
Bio-Path Holdings (BPTH) United States $0.022B 0.00
China SXT Pharmaceuticals (SXTC) China $0.022B 0.00
Melinta Therapeutics (MLNT) United States $0.022B 0.00
Heat Biologics (HTBX) United States $0.016B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.016B 0.00
Regulus Therapeutics (RGLS) United States $0.016B 0.00
Flex Pharma (SLRX) United States $0.015B 0.00
VAXART, INC (VXRT) United States $0.015B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.014B 0.00
Vical (BBI) United States $0.013B 0.00
Cyanotech (CYAN) United States $0.013B 0.00
Lipocine (LPCN) United States $0.009B 0.00
HANCOCK JAFFE (HJLI) United States $0.008B 0.00
Achieve Life Sciences (ACHV) United States $0.007B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.007B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
RXi Pharmaceuticals (PHIO) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Can-Fite Biopharma (CANF) Israel $0.004B 0.00
Hemispherx BioPharma (AIM) United States $0.003B 0.00
Midatech Pharma (MTP) United Kingdom $0.002B 0.00
Onconova Therapeutics (ONTX) United States $0.002B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.001B 0.00
Advanced Accelerator Applications S.A (AAAP) France $0.000B 0.00